GutBrainEducation.Com

Welcome
Your trusted resource for Neurogastroenterology & GI Motility education. We bridge the gap between complex clinical data and real-world relief, offering practical insights for both patients and healthcare providers.

Educational Resources
Irritable Bowel Syndrome (IBS)
Gastroesophageal Reflux Disorder (GERD)
Irritable Bowel Syndrome with Constipation (IBS-C)
Chronic Idiopathic Constipation(CIC)
Slow Transit Constipation
Small Intestinal Bacterial Overgrowth (SIBO)
Inflammatory Bowel Disease (IBD)
Ehlers‑Danlos Syndrome (EDS)
Postural Orthostatic Tachycardia Syndrome (POTS)
Gastroparesis (GP)
Functional Dyspepsia (FD)
Mast Cell Activation Syndrome (MCAS)
Dyssynergic Defecation (DD)
Intestinal Methanogen Overgrowth (IMO)
Small Intestinal Fungal Overgrowth (SIFO)
Fructose Intolerance

Gastroesophageal Reflux Disease (GERD)What is Gastroesophageal Reflux Disease (GERD)?
Gastroesophageal Reflux Disease (GERD) is a chronic digestive condition where stomach acid frequently flows back into the tube connecting your mouth and stomach. This constant backflow can irritate and inflame the sensitive lining of your esophagus over time. While many people experience occasional acid reflux, GERD is diagnosed when these symptoms occur repeatedly and interfere with your daily life. It is a very real physical condition that warrants clinical evaluation rather than relying only on temporary lifestyle fixes. Understanding this condition can help you take control of your digestive health and find lasting comfort.
Gut Brain Interaction
The connection between your brain and your gut plays a major role in how you experience GERD. The Vagus nerve acts as a two-way pathway, constantly sending signals back and forth between your digestive tract and your brain. When you are stressed or anxious, your brain can make your esophagus highly sensitive, causing you to feel even tiny amounts of acid as intense pain. This gut-brain sensitivity often leads to hypervigilance, where you become highly aware of every chest sensation, magnifying your discomfort.
Common Symptoms
- Acid reflux (heartburn) - a burning sensation in the middle of your chest that often rises toward your throat, especially after eating or when lying down.
- Abdominal pain - a painful, aching, or squeezing sensation in your upper stomach area.
- Bloating - a tight, swollen feeling in your belly that makes you feel uncomfortably full.
- Nausea - a sick feeling in your stomach that makes you feel like you might throw up.
- Regurgitation - a sour or bitter-tasting fluid backing up into your mouth or throat.
Common TreatmentsOTC Treatments:
- calcium carbonate (Tums)
- famotidine (Pepcid AC)
- omeprazole (Prilosec OTC)
Prescription Treatments:
- pantoprazole (Protonix)
- prescription-strength famotidine (Pepcid)
- baclofen (Lioresal)
Procedural Treatments:
- Transoral Incisionless Fundoplication (TIF)
- Magnetic sphincter augmentation (LINX system)
- Nissen fundoplication surgery
Herbal Treatments:
- deglycyrrhizinated licorice (DGL)
- chamomile tea
- ginger root extract
Nonpharmacological Treatments:
- Elevating the head of the bed by six inches
- Avoiding trigger foods like chocolate, caffeine, and citrus
- Eating smaller, more frequent meals and not lying down for three hours after eating
Sources
1. American College of Gastroenterology. Acid Reflux. ACG.org. Published May 10, 2021. Accessed July 15, 2026. <u>gi.org</u>
2. Centers for Disease Control and Prevention. GERD and Digestive Health. CDC.gov. Published September 14, 2023. Accessed July 15, 2026. <u>cdc.gov</u>
3. Rao S, Lee YY, Ghoshal UC. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
This information is educational only and not a substitute for medical care.

Irritable Bowel Syndrome (IBS)What is Irritable Bowel Syndrome?
Irritable Bowel Syndrome is a common functional digestive disorder that causes recurring stomach pain, cramping, and changes in bowel habits without any visible damage to your digestive tract. Your symptoms are completely real and valid, even though routine medical tests often come back normal. Specialists manage this condition by focusing on symptom relief, diet adjustments, and calming the nervous system.
Gut Brain Interaction
The signaling between your brain and your digestive tract is overly sensitive and misfiring in Irritable Bowel Syndrome. This hyperactive connection means that normal digestion, stress, or minor gas can trigger severe pain signals through the vagus nerve. Changes in your gut bacteria and daily stress levels can further worsen this visceral hypersensitivity and disrupt normal bowel movements.
Common Symptoms
- Abdominal pain - Sharp or cramping ache that often improves after a bowel movement
- Bloating - Uncomfortable swelling and tightness in the belly
- Diarrhea - Urgent, loose, or watery stools
- Constipation - Hard, difficult to pass stools with a feeling of incomplete emptying
Common TreatmentsOTC:
- loperamide (Imodium)
- polyethylene glycol 3350 (Miralax)
Prescription:
- linaclotide (Linzess)
- dicyclomine (Bentyl)
Herbal:
- peppermint oil (IBgard)
- psyllium husk (Metamucil)
Nonpharmacological:
- Low FODMAP dietary therapy
- Gut directed hypnotherapy
Sources
Rao SSC, Lee YY, Ghoshal UC. Clinical and Basic Neurogastroenterology and Motility. Academic Press. Published 2020. Accessed July 21, 2026. https://www.elsevier.com
American College of Gastroenterology. Irritable Bowel Syndrome. ACG Site. Published 2025. Accessed July 21, 2026. https://gi.org
This information is educational only and not a substitute for medical care.

Irritable Bowel Syndrome with Constipation (IBS-C)What is IBS-C?
Constipation-predominant irritable bowel syndrome (IBS-C) is a chronic functional gastrointestinal disorder characterized by frequent abdominal pain and infrequent, hard, or difficult-to-pass bowel movements. This condition involves altered gut motility without structural damage or visible inflammation in the digestive tract. Patients experience recurring belly discomfort alongside constipation symptoms like straining or a feeling of incomplete evacuation. Management focuses on restoring smooth bowel transit, reducing nerve pain, and improving quality of life through personalized dietary, behavioral, and targeted medical therapies.
Gut Brain Interaction
IBS-C is driven by disrupted signaling between the central nervous system and the enteric nervous system, leading to slowed colonic transit and heightened pain sensitivity. Altered communication along the vagus nerve and spinal pathways creates visceral hypersensitivity, making normal intestinal gas or stool presence feel intensely painful. Delayed muscular contractions in the colon allow excessive water absorption from stool, resulting in hard, dry bowel movements. Psychological stress, anxiety, and microbial imbalances further alter these neural circuits, exacerbating physical discomfort and constipation.
Common Symptoms
- Abdominal pain - crampy belly pain often linked to or relieved by bowel movements
- Infrequent bowel movements - passing fewer than three stools per week
- Straining - severe difficulty or pressure when attempting to pass stool
- Bloating - uncomfortable sensation of abdominal fullness or swelling
Common TreatmentsOTC:
- psyllium (Metamucil)
- polyethylene glycol (Miralax)
- bisacodyl (Dulcolax)
Prescription:
- linaclotide (Linzess)
- lubiprostone (Amitiza)
- plecanatide (Trulance)
Herbal:
- peppermint oil (Ibgard)
- triphala
- ginger root
Nonpharmacological:
- High-fiber dietary adjustments
- Diaphragmatic breathing exercises
- Regular aerobic physical activity
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Management of Irritable Bowel Syndrome Guidelines. ACG Website. Published 2021. Accessed July 21, 2026.
Centers for Disease Control and Prevention. Gastrointestinal Health and IBS. CDC.gov. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Chronic Idiopathic Constipation (CIC)What is Chronic Idiopathic Constipation (CIC)?
Chronic idiopathic constipation (CIC) is a long-term functional gastrointestinal disorder characterized by difficult, infrequent, or incomplete bowel movements without an identifiable structural or metabolic cause. Patients often experience persistent symptoms such as straining, hard stools, abdominal bloating, and a feeling of blockage. Although it causes significant daily discomfort, CIC does not cause structural damage to the digestive tract or increase cancer risk. Management focuses on restoring normal bowel motility, softening stool consistency, and relieving abdominal discomfort through lifestyle, dietary, and medical strategies.
Gut Brain Interaction
Chronic idiopathic constipation stems from altered communication between the central nervous system and the enteric nervous system, resulting in slowed colonic transit and blunted rectal sensation. Impaired coordination along pelvic nerves and spinal pathways disrupts normal colonic peristalsis and pelvic floor muscle relaxation. Visceral hypersensitivity or altered sensory perception can cause persistent feelings of fullness or abdominal pain even when stool volume is low. Stress and microbial imbalances can further alter these neural reflex pathways, worsening bowel transit time.
Common Symptoms
- Infrequent bowel movements - passing fewer than three stools per week
- Hard or lumpy stools - dry, firm bowel movements that are difficult to pass
- Straining - excessive physical effort required during defecation
- Incomplete evacuation - persistent feeling that a bowel movement was not finished
Common TreatmentsOTC:
- polyethylene glycol (Miralax)
- psyllium (Metamucil)
- bisacodyl (Dulcolax)
Prescription:
- linaclotide (Linzess)
- lubiprostone (Amitiza)
- plecanatide (Trulance)
Herbal:
- triphala
- aloe vera juice
- ginger root
Nonpharmacological:
- Gradual increase in dietary soluble fiber
- Increased daily fluid intake
- Abdominal massage and diaphragmatic breathing
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Management of Chronic Constipation Guidelines. ACG Website. Published 2021. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Patient Guide to Chronic Constipation. ANMS Website. Published 2022. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Slow Transit Constipation (STC)What is Slow Transit Constipation (STC)?
Slow transit constipation (STC) is a severe functional gastrointestinal motility disorder characterized by markedly delayed movement of stool through the colon due to impaired colonic neuromuscular activity. Patients experience infrequent bowel movements, severe abdominal bloating, and a complete lack of an urge to defecate. Unlike pelvic floor dyssynergia, STC stems from intrinsic nerve and smooth muscle coordination defects rather than exit obstruction. Management involves prokinetic medications, specialized dietary adjustments, neuromodulation, or surgical evaluation in refractory cases.
Gut Brain Interaction
Slow transit constipation is caused by disrupted neural and pacemaker signaling within the enteric nervous system and central nervous system pathways that govern colonic propulsion. Loss or dysfunction of interstitial cells of Cajal and enteric neurons reduces high-amplitude propagating contractions in the large intestine. Visceral sensory signaling along spinal pathways becomes blunted, impairing the brain's awareness of colonic filling and suppressing the conscious urge to go. Psychological stress and altered neuroendocrine signaling can further slow colonic transit time.
Common Symptoms
- Infrequent bowel movements - passing stools less than once or twice per week
- Absence of urge - lack of normal bodily sensation signaling the need to defecate
- Abdominal distension - persistent swelling, tightness, and severe bloating in the belly
- Mild abdominal pain - dull, aching discomfort associated with prolonged stool retention
Common TreatmentsOTC:
- bisacodyl (Dulcolax)
- senna (Senokot)
- polyethylene glycol (Miralax)
Prescription:
- prucalopride (Motegrity)
- linaclotide (Linzess)
- lubiprostone (Amitiza)
Herbal:
- triphala
- aloe vera juice
- ginger root
Nonpharmacological:
- Sacral nerve stimulation
- Abdominal massage techniques
- Scheduled toilet sitting routines
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Management of Chronic Constipation Guidelines. ACG Website. Published 2021. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Patient Guide to Slow Transit Constipation. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Small Intestinal Bacterial Overgrowth (SIBO)What is SIBO?
Small intestinal bacterial overgrowth (SIBO) is a functional digestive condition where excessive bacteria abnormally colonize the small intestine, disrupting normal digestion and nutrient absorption. Unlike the colon, the small intestine usually maintains low bacterial counts to allow efficient nutrient uptake. When colonic bacteria overpopulate this area, they prematurely ferment food, causing severe gas, bloating, and altered bowel habits. Management focuses on eradicating the overgrowth and restoring normal gut motility to prevent relapse.
Gut Brain Interaction
SIBO is frequently driven by impaired gut-brain nerve signaling that slows down the migrating motor complex, the essential cleansing wave of the small intestine. When vagus nerve-regulated motility is disrupted by severe stress, illness, or structural issues, bacteria are not effectively swept downward into the colon. The resulting bacterial fermentation creates excess hydrogen or methane gas, which aggressively stretches the intestinal walls and triggers intense pain signals back to the central nervous system.
Common Symptoms
- Bloating - severe, uncomfortable abdominal swelling that often visibly worsens after eating
- Abdominal pain - sharp or crampy belly discomfort caused by trapped gas and intestinal distension
- Diarrhea - loose, frequent, watery stools often driven by bile acid malabsorption
- Constipation - infrequent, difficult bowel movements frequently associated with methane-producing organisms
Common TreatmentsOTC:
- botanical polyphenols (Atrantil)
- herbal dysbiosis formulation (CandiBactin AR/BR)
- herbal antimicrobial blend (FC Cidal)
- gut motility supplement (Emma)
Prescription:
- rifaximin (Xifaxan)
- neomycin (Neo-Fradin)
Herbal:
- berberine extract
- oregano oil
- allicin extract
Nonpharmacological:
- elemental diet formulation (mBiota)
- Low-FODMAP dietary adjustments
- Strict meal spacing to stimulate cleansing waves
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Clinical Guideline: Small Intestinal Bacterial Overgrowth. ACG Website. Published 2020. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Patient Guide to SIBO. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Inflammatory Bowel Disease (IBD)What is Inflammatory Bowel Disease (IBD)?
Inflammatory bowel disease (IBD) is a group of chronic autoimmune conditions—including Crohn's disease, ulcerative colitis, and IBD-unspecified—characterized by GI inflammation that disrupts gut motility and tissue structure. Crohn's causes transmural inflammation anywhere in the gut, ulcerative colitis affects the colonic mucosa, and IBD-unspecified shows overlapping features. It most commonly impacts young adults ages 15 to 30 across all demographics. Management focuses on mucosal healing and controlling motility symptoms.
Gut Brain Interaction & Motility Overlap
Intestinal inflammation alters enteric nerve pathways and muscle tone, causing persistent dysmotility, visceral hypersensitivity, and overlapping IBS symptoms even in clinical remission. Cytokines sensitize sensory nerves, lowering pain thresholds and altering gut transit. Impaired cleansing waves also frequently trigger secondary small intestinal bacterial overgrowth (SIBO).
Common Symptoms
- Chronic diarrhea - frequent, urgent, often bloody loose stools
- Abdominal pain - crampy belly pain from inflammation or strictures
- Tenesmus - persistent, painful urge to pass stool with an empty rectum
- Fatigue - systemic exhaustion from inflammation and malabsorption
Testing Modalities
- Colonoscopy with ileoscopy and biopsies
- Fecal calprotectin stool biomarker
- CT or MR enterography imaging
- Hydrogen and methane breath testing
Common TreatmentsTop 5 Biologics:
- infliximab (Remicade)
- adalimumab (Humira)
- vedolizumab (Entyvio)
- ustekinumab (Stelara)
- risankizumab (Skyrizi)
OTC:
- loperamide (Imodium)
- psyllium (Metamucil)
Prescription:
- mesalamine (Lialda)
- dicyclomine (Bentyl)
- rifaximin (Xifaxan)
Herbal:
- curcumin extract
- peppermint oil (Ibgard)
Nonpharmacological:
- Low-FODMAP diet during remission
- Registered dietitian counseling
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. IBD Guidelines. ACG Website. Published 2023. Accessed July 21, 2026.
Crohn's & Colitis Foundation. IBD Guide. CCFA Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Ehlers-Danlos Syndrome (EDS)What is Ehlers-Danlos Syndrome (EDS)?
Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders that causes excessive tissue elasticity, leading to widespread gastrointestinal dysmotility and soft tissue instability. Because collagen provides structural integrity to the digestive tract wall, defective connective tissue causes structural sagging, delayed gastric emptying, and intestinal uncoordination. Patients frequently experience chronic digestive dysfunction, severe heartburn, and unpredictable bowel movements due to impaired tissue tone. Management focuses on supporting gut motility, stabilizing autonomic nerve function, and relieving pain through targeted therapies.
Gut Brain Interaction
Ehlers-Danlos syndrome disrupts gut-brain signaling by altering autonomic nerve pathways, increasing visceral nerve sensitivity, and impairing enteric nervous system communication. Connective tissue laxity surrounding enteric nerves creates mechanical stretching and irritation, which triggers heightened pain signaling to the central nervous system. Co-occurring dysautonomia, such as postural orthostatic tachycardia syndrome, alters blood flow to the digestive tract and impairs vagus nerve regulation. This combination of autonomic dysfunction and nerve hypersensitivity significantly slows digestive transit and amplifies visceral pain perception.
Common Symptoms
- Dysphagia - difficulty swallowing or feeling like food gets stuck in the throat
- Nausea and early satiety - persistent stomach fullness and sickness after just a few bites
- Chronic constipation or diarrhea - unpredictable bowel habits ranging from severe stool delay to sudden loose movements
- Abdominal pain - deep, aching, or burning belly discomfort exacerbated by eating or sitting upright
Common TreatmentsOTC:
- polyethylene glycol (Miralax)
- simethicone (Gas-X)
Prescription:
- pyridostigmine (Mestinon)
- prucalopride (Motegrity)
- linaclotide (Linzess)
Herbal:
- ginger root
- peppermint oil (Ibgard)
Nonpharmacological:
- Small frequent liquid or soft meal strategies
- Postural adjustments and sitting upright after meals
- Abdominal compression garments
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American Neurogastroenterology and Motility Society. GI Manifestations of Connective Tissue Disorders. ANMS Website. Published 2022. Accessed July 21, 2026.
Ehlers-Danlos Society. Gastrointestinal Involvement in EDS. Ehlers-Danlos Society Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Postural Orthostatic Tachycardia Syndrome (POTS)What is Postural Orthostatic Tachycardia Syndrome (POTS)?
Postural orthostatic tachycardia syndrome (POTS) is a form of dysautonomia where the autonomic nervous system fails to regulate blood flow properly, causing an excessive heart rate increase upon standing alongside chronic digestive symptoms. Because the autonomic nervous system controls involuntary functions like heart rate and gut motility, blood pools in the lower body when standing upright. This blood pooling reduces circulation to the digestive tract, leading to delayed stomach emptying and widespread gut dysmotility. Management focuses on expanding blood volume, stabilizing autonomic tone, and targeting specific digestive issues.
Gut Brain Interaction
POTS alters gut-brain communication by disrupting sympathetic and parasympathetic nervous system control over gastrointestinal motility and visceral sensory signaling. When standing, impaired vasoconstriction causes blood to pool in abdominal blood vessels, leading to transient gut ischemia and reflex adrenergic surges. This autonomic imbalance alters vagus nerve regulation and triggers visceral hypersensitivity, amplifying physical sensations like nausea and abdominal cramping. Co-occurring conditions like connective tissue hypermobility or mast cell activation can further destabilize gut-brain coordination.
Common Symptoms
- Nausea - persistent stomach sickness often worsened after eating or standing upright
- Early satiety - feeling uncomfortably full after consuming only a small amount of food
- Abdominal pain - crampy or burning belly discomfort linked to blood pooling and altered motility
- Alternating bowel habits - unpredictable swings between severe constipation and sudden loose stools
Common TreatmentsOTC:
- electrolyte rehydration salts (Liquid I.V.)
- polyethylene glycol (Miralax)
- simethicone (Gas-X)
Prescription:
- fludrocortisone (Florinef)
- midodrine (ProAmatine)
- pyridostigmine (Mestinon)
Herbal:
- ginger root
- peppermint oil (Ibgard)
Nonpharmacological:
- High-sodium diet and high fluid intake
- Abdominal compression garments and binders
- Small, frequent, low-carbohydrate meals
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
Dysautonomia International. Gastrointestinal Involvement in POTS. Dysautonomia International Website. Published 2022. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Autonomic Disorders and GI Dysmotility. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

GastroparesisWhat is Gastroparesis?
Gastroparesis is a chronic neurogastroenterological disorder characterized by delayed gastric emptying in the absence of mechanical obstruction. Patients experience persistent upper digestive symptoms because stomach muscle contractions fail to propel food efficiently into the small intestine. The condition is definitively diagnosed using nuclear gastric emptying studies to quantify food retention over time. Management relies on a combination of a specialized gastroparesis diet, targeted prokinetic and antiemetic medications, and procedural interventions.
Gut Brain Interaction
Gastroparesis stems from impaired vagus nerve signaling and intrinsic enteric nervous system damage that disrupts gastric motility and sensory pathways. Loss of interstitial cells of Cajal destroys normal pacemaker rhythmicity, impairing stomach contractions and causing pyloric dysfunction. Visceral hypersensitivity along spinal nerve pathways causes normal stomach filling to be perceived as severe nausea or pain by the central nervous system. Autonomic nervous system stress responses further inhibit gastric motility and amplify symptom perception.
Common Symptoms
- Nausea - persistent stomach sickness often leading to vomiting
- Early satiety - uncomfortably full feeling after eating small portions
- Postprandial fullness - heavy, prolonged abdominal fullness after meals
- Upper abdominal pain - burning or aching discomfort in the upper stomach
Common TreatmentsOTC:
- simethicone (Gas-X)
Prescription:
- metoclopramide (Reglan)
- metoclopramide nasal spray (Gimoti)
- prucalopride (Motegrity)
- ondansetron (Zofran)
- mirtazapine (Remeron)
- buspirone (Buspar)
Procedural:
- Gastric electric stimulators
- Gastric peroral endoscopic myotomy (G-POEM)
- Endoscopic pyloric dilation
- Pyloric onabotulinumtoxinA (Botox) injections
Herbal:
- ginger root
- peppermint oil
Nonpharmacological:
- Low-fat low-fiber gastroparesis diet
- Small frequent liquid or puree meal adjustments
- Post-meal upright sitting posture
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Clinical Guideline: Management of Gastroparesis. ACG Website. Published 2022. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Patient Guide to Gastroparesis. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Functional Dyspepsia (FD)What is Functional Dyspepsia (FD)?
Functional dyspepsia is a common gut-brain interaction disorder causing persistent upper abdominal symptoms like pain, burning, or early fullness without structural disease. It arises from abnormal stomach nerve sensitivity, impaired gastric accommodation, or delayed emptying. Patients experience chronic upper digestive discomfort that requires a combined management approach.
Subtypes of Functional Dyspepsia
Functional dyspepsia is categorized into two main clinical subtypes based on whether symptoms are triggered by meals or occur independently. Postprandial distress syndrome causes uncomfortable post-meal fullness and early satiation after eating normal portions. Epigastric pain syndrome features upper abdominal pain or burning that is not restricted to post-meal periods.
Gut Brain Interaction
Functional dyspepsia is caused by disrupted neural signaling between the brain and stomach that heightens visceral sensitivity and impairs stomach muscle relaxation. Miscommunication along vagus nerve pathways causes normal stomach filling to be processed as severe pain or nausea. Stress and anxiety further alter these central circuits, worsening upper stomach motor and nerve function.
Common Symptoms
- Postprandial fullness - uncomfortable feeling of food sitting in the stomach
- Early satiation - feeling full prematurely after eating a small amount
- Epigastric pain - aching discomfort located in the upper belly
- Epigastric burning - uncomfortable heat sensation in the upper stomach
Common TreatmentsOTC:
- IBgard
- Iberogast
Prescription:
- amitriptyline (Elavil)
- mirtazapine (Remeron)
- buspirone (Buspar)
- Duloxetine
- Gabapentin
Herbal:
- peppermint oil and caraway oil
- ginger root
Nonpharmacological:
- Small, frequent, low-fat meal adjustments
- Diaphragmatic breathing after eating
- Cognitive behavioral therapy
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Management of Dyspepsia Guidelines. ACG Website. Published 2022. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Patient Guide to Functional Dyspepsia. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Mast Cell Activation Syndrome (MCAS)What is Mast Cell Activation Syndrome (MCAS)?
Mast cell activation syndrome (MCAS) is an immunological disorder where mast cells inappropriately release excessive inflammatory mediators, causing recurrent multisystem allergic symptoms and severe digestive dysmotility. Affected individuals experience unpredictable gastrointestinal symptoms alongside systemic features like flushing, hives, and brain fog without evidence of clonal mast cell proliferation. This condition frequently co-occurs alongside hypermobile Ehlers-Danlos syndrome, postural orthostatic tachycardia syndrome, small intestinal bacterial overgrowth, and irritable bowel syndrome. Comprehensive management requires a multidisciplinary care team including allergists, immunologists, and neurogastroenterology specialists.
Gut Brain Interaction and Crossovers
Mast cell activation disrupts gut-brain signaling when released histamine, tryptase, and prostaglandins directly sensitize enteric sensory nerves and excite vagal pathways. These inflammatory mediators trigger visceral hypersensitivity, altered smooth muscle tone, and rapid mucosal fluid secretion, leading to severe abdominal pain and erratic bowel movements. Chronic neuroimmune activation lowers the visceral pain threshold, causing normal digestive processes and food intake to feel intensely painful.
Common Symptoms
- Abdominal pain - severe crampy belly discomfort triggered by food ingestion
- Unpredictable diarrhea or nausea - sudden loose stools or persistent stomach sickness
- Food intolerances - acute physical reactions to multiple food groups
- Systemic flushing or hives - sudden skin redness, itching, or swelling
Diagnostic Testing and Lab Findings
- Serum total tryptase baseline and acute flare testing
- 24-hour urine N-methylhistamine and prostaglandin F2alpha
- Chromogranin A blood levels
- Endoscopic mucosal biopsies with CD117 mast cell staining
Common TreatmentsOTC:
- cetirizine (Zyrtec)
- fexofenadine (Allegra)
- famotidine (Pepcid)
Prescription:
- cromolyn sodium (Gastrocrom)
- ketotifen (Zaditen)
- montelukast (Singulair)
Herbal:
- quercetin extract
- luteolin extract
Nonpharmacological:
- Low-histamine dietary modifications
- Elimination of identified chemical triggers
- Diaphragmatic breathing and stress reduction
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American Academy of Allergy Asthma and Immunology. Mast Cell Activation Syndrome Guide. AAAAI Website. Published 2023. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Neurogastroenterology and Mast Cell Disorders. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Dyssynergic Defecation (DD)What is Dyssynergic Defecation?
Dyssynergic defecation is a functional pelvic floor disorder characterized by an inability to coordinate abdominal and anal sphincter muscles during bowel movements. Patients experience chronic constipation and severe straining because the anal sphincter paradoxically contracts or fails to relax when pushing. It is divided into four main subtypes based on abdominal push force and sphincter behavior. Treating colonic motility with laxatives without correcting this exit obstruction leads to treatment failure, cramping, and paradoxical diarrhea around impacted stool.
Diagnostic Metrics & Biofeedback Tailoring
Diagnostic metrics from anorectal manometry dictate the specific neuromuscular focus during biofeedback therapy. Elevated sphincter pressures and paradoxical contraction require targeted relaxation retraining, while altered rectal sensory thresholds necessitate balloon sensory discrimination training. The balloon expulsion test confirms functional outlet obstruction, and a present rectoanal inhibitory reflex (RAIR) rules out nerve aganglionosis. Guided biofeedback achieves a 70% to 80% long-term success rate, vastly outperforming laxatives alone.
Four Subtypes
- Type I - High push pressure with paradoxical sphincter contraction
- Type II - Low push pressure with paradoxical sphincter contraction
- Type III - High push pressure with incomplete sphincter relaxation
- Type IV - Low push pressure with incomplete sphincter relaxation
Common TreatmentsOTC & Prescription:
- polyethylene glycol (Miralax)
- linaclotide (Linzess)
- prucalopride (Motegrity)
Procedural & Behavioral:
- Anorectal biofeedback neuromuscular training
- Toilet posture alignment footstools (Squatty Potty)
- Diaphragmatic breathing and expulsion dynamics
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American Neurogastroenterology and Motility Society. Dyssynergic Defecation Guide. ANMS Website. Published 2022. Accessed July 21, 2026.
American College of Gastroenterology. Chronic Constipation Guidelines. ACG Website. Published 2021. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Intestinal Methanogen Overgrowth (IMO)What is Intestinal Methanogen Overgrowth (IMO)?
Intestinal methanogen overgrowth (IMO) is a digestive condition where methane-producing organisms, primarily Methanobrevibacter smithii, overpopulate the small intestine and large intestine to slow bowel motility. Methane gas acts as a local neuromuscular agent, delaying intestinal transit time and causing severe chronic constipation, intense bloating, and visible belly distension.
Causes, Risk Factors, and Recurrence
IMO is driven by delayed GI transit and underlying autonomic or connective tissue disorders like Ehlers-Danlos syndrome, POTS, mast cell activation syndrome, and dyssynergic defecation, carrying recurrence rates over 40 percent. Slow intestinal transit allows methanogens to persist and multiply, making long-term motility optimization essential to prevent rapid relapse.
Testing and Retreatment Guidelines
IMO is diagnosed using a lactulose or glucose hydrogen-methane breath test that demonstrates a methane level of 10 parts per million or higher at any point during testing. Routine retesting before every treatment cycle is generally unnecessary, as clinicians guide retreatment on returning signs like renewed constipation and distension while preventing overtreatment through prokinetics.
Common TreatmentsOTC and Online Options:
- botanical polyphenols (Atrantil)
- herbal dysbiosis formulation (CandiBactin AR)
- herbal antimicrobial blend (FC Cidal)
- gut motility supplement (Emma)
- berberine extract
Prescription:
- rifaximin (Xifaxan) combined with neomycin (Neo-Fradin)
- prucalopride (Motegrity) for motility maintenance
Nonpharmacological and Last Resort:
- elemental diet formulation (mBiota) as a last ditch option
- Low-FODMAP dietary modifications
- Strict meal spacing to stimulate cleansing waves
- Spore-based probiotics used short term for 4 to 8 weeks
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Small Intestinal Bacterial Overgrowth Guidelines. ACG Website. Published 2020. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Guide to Methane Overgrowth and Motility. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.

Small Intestinal Fungal Overgrowth (SIFO)What is SIFO?
Small intestinal fungal overgrowth (SIFO) is a digestive condition where excessive fungal species, primarily Candida, overpopulate the small intestine to cause chronic abdominal symptoms. Normal small bowel motility keeps fungal counts low, but impaired transit allows overgrowth that triggers severe bloating, gas, nausea, and belly pain. Symptoms closely mirror SIBO and IMO, presenting with postprandial fullness, belching, and loose stools or constipation.
Causes, Risk Factors, and Recurrence
SIFO is driven by altered GI motility, chronic acid suppression, and immune dysfunction, carrying symptom recurrence rates over 40 percent. Long-term antibiotics disrupt competitive bacterial populations, while delayed transit lets fungal spores multiply. Patients with gastroparesis, Ehlers-Danlos syndrome, POTS, diabetes, or prior abdominal surgeries are especially prone. Cleared with 2 to 3 week antifungal courses, retreatments may be necessary when underlying motility remains impaired.
Diagnostic Testing
SIFO is diagnosed exclusively through an upper endoscopy with a small intestine endoscopic fluid culture. Breath tests cannot detect fungal overgrowth because fungi produce different metabolic gases than bacteria. Obtaining a sterile aspirate from the duodenum or jejunum during an upper endoscopy is the sole clinical method to confirm elevated fungal colony counts.
Common TreatmentsPrescription:
- fluconazole (Diflucan)
- itraconazole (Sporanox)
- nystatin (Bio-Statin)
OTC & Herbal:
- caprylic acid extract
- oregano oil
- berberine extract
Nonpharmacological & Diet:
- Low-sugar and low-refined carbohydrate dietary adjustments
- Low-FODMAP dietary strategies
- Strict meal spacing to stimulate cleansing motility waves
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Small Intestinal Fungal Overgrowth Guide. ACG Website. Published 2021. Accessed July 21, 2026.
American Neurogastroenterology and Motility Society. Fungal Overgrowth and Gut Motility. ANMS Website. Published 2023. Accessed July 21, 2026.
This information is educational only and not a substitute for medical care.


Fructose Intolerance

What is Fructose Intolerance?
Fructose intolerance happens when the small intestine cannot properly absorb fructose sugar. This sugar is found naturally in fruits, vegetables, and high-fructose corn syrup. Unabsorbed sugar moves into the large intestine, where normal bacteria ferment it. This process creates excess gas and draws water into the colon. It leads to distressing symptoms like bloating, abdominal cramps, and frequent diarrhea. While these symptoms cause anxiety, the condition is harmless and manageable with dietary changes.
Gut Brain Interaction
The gut and brain talk constantly via the gut-brain axis and the Vagus nerve. Fermentation gas stretches the intestinal walls, which prompts the Vagus nerve to send distress signals to the brain. Many people experience visceral hypersensitivity, where the brain amplifies these normal signals. This makes standard digestion feel painful, fueling hypervigilance and anxiety over abdominal sensations.
Common Symptoms
- Abdominal pain - sharp cramping or aches worsening after eating sweets.
- Bloating and gas - a tight, swollen stomach feeling like an inflated balloon.
- Diarrhea - loose, watery stools from sugar drawing fluid into the colon.
- Nausea - an uneasy stomach feeling often triggered by sweet food choices.
- Constipation - infrequent or hard stools from altered gut motility patterns.
Common Treatments
OTC:
- xylose isomerase (Fructaid) to aid fructose breakdown.
- loperamide (Imodium) to control watery stools.
- bismuth subsalicylate (Pepto-Bismol) to soothe upset stomach.
Prescription:
- rifaximin (Xifaxan) for secondary bacterial overgrowth.
- dicyclomine (Bentyl) to reduce intestinal spasms.
- amitriptyline (Elavil) to lower gut pain sensitivity.
Procedural:
- Hydrogen breath testing to confirm malabsorption.
- Nutritional consultation to plan an elimination diet.
- Upper endoscopy to rule out inflammatory conditions.
Herbal:
- Peppermint oil (IBgard) to relax muscles and gas.
- Ginger root extract to soothe nausea and support motility.
- Chamomile tea to calm spasms and reduce stress.
Nonpharmacological:
- Low-FODMAP diet to remove trigger foods.
- Diaphragmatic breathing to help lower pain.
- Gut-directed hypnotherapy to retrain brain signals.
Common Trigger Foods
Apples
Pears
Mango
Honey
High-fructose corn syrup
Fruit juice
Watermelon
Agave syrup
Sugar-free gum containing sorbitol
Dried fruit such as raisins or dates
Sources
Gibson P, Halmos E. FODMAPs and carbohydrate intolerance. Clin Basic Neurogastroenterol Motil. 2020. elsevier.com
American College of Gastroenterology. Bloating & Flatulence. ACG. 2021. gi.org
ANMS. Patient education on dietary intolerances. ANMS. 2022. anms.org
Disclaimer
This information is educational only and not a substitute for medical care.

Anthony Rosario PA-C, MS
Neurogastroenterology & Motility Physician Assistant

Education
Master of Science – Physician Assistant Studies, Touro College, New York City, New York
Bachelor of Science – Physician Assistant Studies, Pennsylvania College of Technology, Williamsport, Pennsylvania
Bachelor of Science – Biology, The Pennsylvania State University, University Park, Pennsylvania

About Me
I am an NCCPA Certified Physician Assistant (PA‑C) specializing in Gastrointestinal Motility and Neurogastroenterology.
My clinical work centers on diagnosing and treating Disorders of Gut–Brain Interaction (DGBI) and complex motility conditions, including Gastroparesis, Irritable Bowel Syndrome with Constipation (IBS‑C), Irritable Bowel Syndrome with Diarrhea (IBS‑D), Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methanogen Overgrowth (IMO), Small Intestinal Fungal Overgrowth (SIFO), Dyssynergic Defecation, and Fecal Incontinence.Clinical Practice
I work daily within a multidisciplinary GI, Motility and Neurogastroenterology team, collaborating closely with physicians, nurses, and motility specialists. I Order and interpret advanced diagnostic testing and therapeutic procedures, including Bravo pH Capsule Studies, Breath Testing for SIBO, Fructose , Fructan, Lactose Malabsorption & Intolerance. Gastric Stimulator Management, Digestive Enzyme Testing, Anorectal Manometry and Anorectal Biofeedback Therapy.

Popular Diets for IBS

What is the Low FODMAP diet?
The Low FODMAP diet is a specialized dietary approach designed to manage uncomfortable gastrointestinal symptoms like bloating, gas, and abdominal pain. FODMAPs are short-chain carbohydrates that are poorly absorbed in the small intestine. When these fermentable sugars pass into the large intestine, they pull in excess water and are rapidly fermented by gut bacteria. This process produces gas, leading to stretching of the intestinal walls and discomfort. Eliminating high-FODMAP foods and systematically reintroducing them helps identify specific personal food triggers.
Gut Brain Interaction
The gut and the brain communicate constantly through a complex network known as the gut-brain axis, largely mediated by the vagus nerve. In individuals with gut-brain interaction disorders, the nerves in the intestinal wall often become hyper-reactive to normal digestive processes. When fermentable sugars draw water and create gas, the resulting intestinal distension sends exaggerated pain signals up the vagus nerve to the brain. This heightened perception can trigger central stress responses, which in turn alter gut motility and worsen physical symptoms.
Common Symptoms
- Abdominal pain - feels like cramping, aching, or sharp discomfort triggered after eating high-fermentation foods
- Bloating - feels like intense internal tightness or a swollen, distended abdomen from trapped gas
- Gas - increased flatulence and burping as gut bacteria ferment unabsorbed carbohydrates
- Diarrhea - loose or watery stools caused by excess fluid drawn into the bowel
- Constipation - infrequent or difficult bowel movements resulting from altered gut motility
- Nausea - an uneasy feeling in the stomach often linked to delayed gastric emptying or severe distension
Common Treatments
- Over-the-Counter (OTC)
- alpha-galactosidase (Beano)
- lactase enzyme (Lactaid)
- simethicone (Gas-X)
Prescription
- dicyclomine (Bentyl)
- rifaximin (Xifaxan)
- hyoscyamine (Levsin)
Tests
- Hydrogen and methane breath testing
- Dietary reintroduction monitoring
- Anorectal manometry
Herbal
- peppermint oil (Colpermin)
- Chamomile tea
- Ginger root
Nonpharmacological
- Cognitive behavioral therapy
- Gut-directed hypnotherapy
- Diaphragmatic breathing exercises
Sources
Rao SSC, Lee YY, Ghoshal UC, eds. Clinical and Basic Neurogastroenterology and Motility. Academic Press; 2020.
American College of Gastroenterology. Irritable Bowel Syndrome Management Guidelines. ACG.gi.org. Published January 1, 2021. Accessed July 20, 2026. acg.gi.orgCenters for Disease Control and Prevention. Inflammatory Bowel Disease & Digestive Health. CDC.gov. Published April 15, 2024. Accessed July 20, 2026. cdc.govDisclaimer
This information is educational only and not a substitute for medical care.